Overactive Bladder: Slideshow
ISC 2010: Top Research Slideshow-
Is Hospitalization Associated With Cognitive Decline in Older Adults?
-
Anti-N-methyl-D-aspartate Receptor Encephalitis
-
Carotid Stenting Still Controversial?
-
CREST Results: Carotid Endarterectomy vs Stenting
-
Pediatric Stroke: Causes and Management
-
Psychotropic Therapy in Suicidal Adolescents: Effective in Reducing Readmission?
-
CDC Commentary: Duchenne Muscular Dystrophy -- Considerations for Care
-
AAPM 2009 Expert Video: A Primary Care Perspective
-
AAPM 2009 Expert Video: Multimodal Therapy in Pain
-
TPA 3.0-4.5 Hours After Acute Stroke: A Subgroup Analysis
-
The Role of Mild Induced Hypothermia in Cardiac Arrest
-
Naproxcinod -- Does This New Drug Mean That Safe Pain Relief Is at Hand?
AAPM 2010: Top Research Slideshow
Diseases of the Nails: Slideshow
Antipsychotics in Children and the Elderly: Controversies, Issues, and Ethics: Slideshow
Leprosy: Slideshow
Radiological Society of North America (RSNA) 2009 Annual Meeting: Slideshow
Pain Management: Slideshow
Creutzfeldt-Jakob Disease: Slideshow
Acute Stroke: Slideshow
Neurocysticercosis: Slideshow 
Recognizing Child Abuse: Slideshow
Carpal Tunnel Syndrome: Slideshow
Community Blogs
Commentary and Interviews
POLL
Neurology on the Hill, a group of 100+ neurologists from AAN, met with members of Congress last week to advocate change, such as neurologists becoming the primary providers for complex neurological conditions, and to express concern over cuts to Medicare reimbursements. How persuasive do you think Neurology on the Hill was this year to lawmakers?
Advisory Board
Site Editorial Director
- ABILIFY® (aripiprazole)
- Clinical Management Center
- NUCYNTA™ (tapentadol)
- NUVIGIL® (armodafinil) Tablets [C-IV]
- OPANA® ER (oxymorphone HCl)
- PLAVIX® (clopidogrel bisulfate) Explore this extensive on-line informational resource
- REBIF® (interferon beta-1a)
- STALEVO® (carbidopa, levodopa and entacapone) tablets
Also of Interest
- AMA Supports Latest Healthcare Reform Legislation With Reservations
- Alert High-Dose Simvastatin Associated With Increased Risk for Myopathy, FDA Warns
Guidelines in the News
Genomics and Neurology
- Whole Genome Sequencing Hits the Clinic for Diagnosis in Charcot-Marie-Tooth Neuropathy
- A Genetic Panel With That Dilantin Level, Please?
